お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:体外診断:各種技術・世界の市場
市場調査レポート
商品コード
999402

体外診断:各種技術・世界の市場

In Vitro Diagnostics: Technologies and Global Markets

出版日: | 発行: BCC Research | ページ情報: 英文 302 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.93円
体外診断:各種技術・世界の市場
出版日: 2021年04月06日
発行: BCC Research
ページ情報: 英文 302 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の体外診断 (IVD) の市場規模は予測期間中6.7%のCAGRで推移し、2020年の741億米ドルから、2025年には1024億米ドルの規模に成長すると予測されています。

地域別で見ると、北米地域が期間中3.4%のCAGRで推移し、2020年の311億米ドルから、2025年には369億米ドルに成長すると予測されています。また、アジア太平洋地域は同期間中13.5%のCAGRで推移し、2020年の185億米ドルから、2025年には348億米ドルの規模に成長すると予測されています。

当レポートでは、世界の体外診断 (IVD) の市場を調査し、市場の概要・背景、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、関連法規制、技術・特許の動向、市場規模の推移・予測、検査区分・地域/主要国別の詳細分析、企業および企業間の取り組み・展開、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 市場情勢

  • COVID-19の世界的流行
  • COVID-19検査の概要
  • 代替オプションによる診断検査
  • 分子診断検査
  • 検査へのアクセスの増加
  • 抗原検査
  • 抗体(血清学)検査
  • 体外診断検査の緊急使用許可 (EUA)
  • 診断検査
  • 血清・抗体検査
  • COVID-19患者の管理のための検査
  • 市場概要・市場区分
  • 主要調査結果
  • 市場影響因子
  • 促進要因
  • 課題
  • 規制状況
  • IVD規制:北米
  • IVD規制:欧州
  • IVD規制:アジア太平洋
  • IVD規制:ラテンアメリカ・アフリカ・中東

第4章 世界のIVD市場:製品区分別

  • 免疫化学
  • POC IVD
  • 分子診断検査
  • 血液検査
  • 臨床微生物検査
  • 組織診断検査
  • 動向
  • 競合構造
  • 市場シェア分析

第5章 免疫化学検査部門の分析・予測

  • 血液ガス・電解質・代謝物(BGEM)
  • 内分泌
  • 感染症
  • 尿検査
  • 糖尿病
  • 心臓病
  • 血液スクリーニング
  • その他
  • FDAによる製品承認

第6章 POC検査部門の分析・予測

  • ブドウ糖検査
  • BGEM
  • 心臓マーカー検査
  • 感染症検査
  • 妊娠検査・不妊検査
  • 薬物・アルコール乱用検査
  • 血液・止血検査
  • コレステロール検査
  • 尿化学検査
  • 腫瘍マーカー検査
  • その他
  • FDAによる製品承認

第7章 血液検査部門の分析・予測

  • 定期的な血液検査
  • 止血
  • FDAによる製品承認

第8章 分子診断検査部門の分析・予測

  • 感染症
  • 血液スクリーニング
  • 腫瘍
  • 遺伝子検査
  • その他(コンパニオン診断、出生前遺伝子検査、希少疾患)
  • FDAによる製品承認

第9章 臨床微生物検査部門の分析・予測

  • 血液培養
  • 一般的な培養(尿・唾液・便・痰・CSF・その他)
  • 同定・抗生物質感受性試験
  • FDAによる製品承認

第10章 組織診断検査部門の分析・予測

  • 癌診断
  • 組織タイピング
  • 病原体検出

第11章 市場分析・予測:地域・主要国別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ・アフリカ・中東

第12章 市場動向

  • エンドユーザー
  • 製品カテゴリー
  • 技術動向
  • 産業における展開
  • 市場機会

第13章 M&A

第14章 特許レビュー

第15章 企業プロファイル

  • ABBOTT DIAGNOSTICS INC.
  • ALERE SAN DIEGO INC.
  • ASCENSIA DIABETES CARE
  • BECKMAN COULTER (PART OF DANAHER)
  • BECTON DICKINSON AND CO.
  • BIOMERIEUX
  • BIO-RAD
  • DANAHER CORP.
  • ELITECH GROUP
  • HOLOGIC INC.
  • INSTRUMENTATION LABORATORY
  • KEMENTEC A/S
  • ORTHO CLINICAL DIAGNOSTICS
  • ROCHE DIAGNOSTICS CORP.
  • QUIDEL CORP.
  • SIEMENS HEALTHCARE DIAGNOSTICS INC.
  • SYSMEX
  • THERMO FISHER SCIENTIFIC INC.
  • TRANSASIA BIO-MEDICALS
  • WERFEN GROUP

第16章 付録

図表

List of Tables

  • Summary Table : Global Market for In Vitro Diagnostics (IVD), by Region, Through 2025
  • Table 1 : Total Cumulative Cases of COVID-19, by WHO Region/Country, as of 2/10/2021
  • Table 2 : Different Types of Coronavirus Tests, 2020
  • Table 3 : Individual EUAs for Molecular Diagnostic Tests for SARS-CoV-2 as of 2/1/2021
  • Table 4 : Authorized Molecular-Based Laboratory Developed Tests for Detection of Nucleic Acid from SARS-CoV-2, as of 2/1/2021
  • Table 5 : Individual EUAs for Antigen Diagnostic Tests for SARS-CoV-2, as of 2/1/2021
  • Table 6 : Individual EUAs for Serology Tests for SARS-CoV-2, as of 2/1/2021
  • Table 7 : Individual EUAs for IVDs for the Management of COVID-19 Patients, as of 2/1/2021
  • Table 8 : Types of Diagnostic Tests and How They are Regulated
  • Table 9 : Changes in IVD Regulations in Asia-Pacific, 2020
  • Table 10 : Global Market for IVD, by Segment, Through 2025
  • Table 11 : Global Company Market Shares of IVD, 2020
  • Table 12 : Global Market for Immunochemistry Testing, by Application, Through 2025
  • Table 13 : Global Market for Immunochemistry Testing, by Region, Through 2025
  • Table 14 : FDA Immunology Products Approved in 2020
  • Table 15 : Global Market for POC Testing, by Application, Through 2025
  • Table 16 : Global Market for POC Testing, by Region, Through 2025
  • Table 17 : FDA POC Products Approved in 2020
  • Table 18 : Global Market for Hematology Testing, by Application, Through 2025
  • Table 19 : Global Market for Hematology Testing, by Region, Through 2025
  • Table 20 : FDA Hematology Products Approved in 2020
  • Table 21 : FDA Immunohematology Products Approved in 2020
  • Table 22 : Global Market for Molecular Diagnostic Testing, by Application, Through 2025
  • Table 23 : Global Market for Molecular Diagnostic Testing, by Region, Through 2025
  • Table 24 : FDA-Approved Nucleic Acid-Based Human Genetic Tests, as of 2/1/2021
  • Table 25 : FDA-Approved Nucleic Acid Based Microbial Tests, as of 2/1/2021
  • Table 26 : List of Cleared or Approved Companion Diagnostic Devices,2/4/2021
  • Table 27 : Global Market for Clinical Microbiology Testing, by Application, Through 2025
  • Table 28 : Global Market for Clinical Microbiology Testing, by Region, Through 2025
  • Table 29 : FDA Bacteriology Products Approved in 2020
  • Table 30 : FDA Virology Products Approved in 2020
  • Table 31 : Global Market for Tissue Diagnostic Testing, by Application, Through 2025
  • Table 32 : Global Market for Tissue Diagnostic Testing, by Region, Through 2025
  • Table 33 : Global COVID-19 Prevalence, by WHO Region/Country, 2/10/2021
  • Table 34 : Global Market for IVD, by Region, Through 2025
  • Table 35 : Global Market Shares of IVD, by Region, 2019-2025
  • Table 36 : North American Market for IVD, by Segment, Through 2025
  • Table 37 : North American Market for Immunochemistry Testing, by Segment, Through 2025
  • Table 38 : North American Market for POC Testing, by Segment, Through 2025
  • Table 39 : North American Market for Hematology Testing, by Segment, Through 2025
  • Table 40 : North American Market for Molecular Diagnostic Testing, by Segment, Through 2025
  • Table 41 : North American Market for Microbiology Diagnostic Testing, by Segment, Through 2025
  • Table 42 : North American Market for Tissue Diagnostic Testing, by Segment, Through 2025
  • Table 43 : European Market for IVD, by Segment, Through 2025
  • Table 44 : European Market for Immunochemistry Testing, by Segment, Through 2025
  • Table 45 : European Market for POC Testing, by Segment, Through 2025
  • Table 46 : European Market for Hematology Testing, by Segment, Through 2025
  • Table 47 : European Market for Molecular Diagnostic Testing, by Segment, Through 2025
  • Table 48 : European Market for Microbiology Testing, by Segment, Through 2025
  • Table 49 : European Market for Tissue Diagnostic Testing, by Segment, Through 2025
  • Table 50 : Asia-Pacific Market Shares of IVD, by Country, 2020
  • Table 51 : Asia-Pacific Market for IVD, by Segment, Through 2025
  • Table 52 : Asia-Pacific Market for Immunochemistry Testing, by Segment, Through 2025
  • Table 53 : Asia-Pacific Market for POC Testing, by Segment, Through 2025
  • Table 54 : Asia-Pacific Market for Hematology Testing, by Segment, Through 2025
  • Table 55 : Asia-Pacific Market for Molecular Diagnostic Testing, by Segment, Through 2025
  • Table 56 : Asia-Pacific Market for Clinical Microbiology Testing, by Segment, Through 2025
  • Table 57 : Asia-Pacific Market for Tissue Diagnostic Testing, by Segment, Through 2025
  • Table 58 : LAAM Market for IVD, by Segment, Through 2025
  • Table 59 : LAAM Market for Immunochemistry Testing, by Segment, Through 2025
  • Table 60 : LAAM Market for POC Testing, by Segment, Through 2025
  • Table 61 : LAAM Market for Hematology Testing, by Segment, Through 2025
  • Table 62 : LAAM Market for Molecular Diagnostic Testing, by Segment, Through 2025
  • Table 63 : LAAM Market for Clinical Microbiology Testing, by Segment, Through 2025
  • Table 64 : LAAM Market for Tissue Diagnostic Testing, by Segment, Through 2025
  • Table 65 : U.S. FDA Approvals of High-Complexity IVD Products, 2019-2020
  • Table 66 : Diagnostics Manufacturer Mergers and Acquisitions, 2004-2020
  • Table 67 : U.S. COVID-19-Related Patents, 2020

List of Figures

  • Summary Figure : Global Market for In Vitro Diagnostics (IVD), by Region, 2019-2025
  • Figure 1 : Global Market for IVD, by Segment, 2019-2025
  • Figure 2 : Global Market Shares of IVD, by Segment, 2020
  • Figure 3 : Global Market Shares of Immunochemistry Testing, by Application, 2020
  • Figure 4 : Global Market for Immunochemistry Testing, by Region, 2019-2025
  • Figure 5 : Global Market for POC Testing, by Application, 2019-2025
  • Figure 6 : Global Market for POC Testing, by Region, 2019-2025
  • Figure 7 : Global Market for Hematology Testing, by Application, 2019-2025
  • Figure 8 : Global Market Shares of Hematology Testing, by Technique, 2020
  • Figure 9 : Global Market Shares of Hematology Testing, by System, 2020
  • Figure 10 : Global Market for Hematology Testing, by Region, 2019-2025
  • Figure 11 : Global Market for Molecular Diagnostic Testing, by Application, 2019-2025
  • Figure 12 : Global Market Shares of Molecular Diagnostic Testing, by Application, 2020
  • Figure 13 : Global Market Shares of Molecular Diagnostic Testing, by Infectious Disease, 2020
  • Figure 14 : Global Market for Molecular Diagnostic Testing, by Region, 2019-2025
  • Figure 15 : Global Market for Clinical Microbiology Testing, by Application, 2019-2025
  • Figure 16 : Global Market Shares of Clinical Microbiology Testing, by Application, 2020
  • Figure 17 : Global Market for Clinical Microbiology Testing, by Region, 2019-2025
  • Figure 18 : Global Market for Tissue Diagnostic Testing, by Application, 2019-2025
  • Figure 19 : Global Market Shares of Tissue Diagnostic Testing, by Application, 2020
  • Figure 20 : Global Market for Tissue Diagnostic Testing, by Region, 2019-2025
  • Figure 21 : European Market Shares of IVD, by Country, 2020
  • Figure 22 : Western European Market Shares of IVD, by Country, 2020
  • Figure 23 : Central and Eastern European Market Shares of IVD, by Country, 2020
  • Figure 24 : Latin American Market Shares of IVD, by Country, 2020
  • Figure 25 : Middle East and African Market Shares of IVD, by Region, 2020
  • Figure 26 : Global Market Shares of IVD, by End User, 2020
  • Figure 27 : Global Market Shares of IVD, by Product Type, 2020
目次
Product Code: HLC186C

Highlights:

The global market for in vitro diagnostics (IVD) should increase from $74.1 billion in 2020 to reach $102.4 billion by 2025, at a compound annual growth rate (CAGR) of 6.7% during the period of 2020-2025.

The North American market for IVD should increase from $31.1 billion in 2020 to reach $36.9 billion by 2025, at a CAGR of 3.4% during the period of 2020-2025.

The Asia-Pacific market for IVD should increase from $18.5 billion in 2020 to reach $34.8 billion by 2025, at a CAGR of 13.5% during the period of 2020-2025.

Report Scope:

The scope of this study is global. BCC Research analyzes each market and its applications, regulatory environment, technologies involved, market projections and market shares. The emerging markets discussed include countries such as India, China, Korea, Taiwan, Africa, Australia, Brazil and Russia, among others. The report also examines IVD market drivers, as well as restraints and challenges affecting its growth. Further, the report also highlights the emerging products and technologies and associated start-ups that are likely to accelerate the growth of the IVD industry through their best practices in the research and development of IVDs. Excluded from this study is diagnostic testing such as imaging, veterinary diagnostics and their associated products.

This study will provide information on these areas -

  • Structure and current market size of the IVD market as outlined with forecasts through 2025.
  • Impact of chronic diseases, growing and aging populations.
  • Current technology and product suppliers and key innovations.
  • A look at the IVD industry and trends affecting the market.
  • Markets by each segment (immunochemistry, molecular diagnostics, POC tests, clinical microbiology, hematology and tissue diagnostics).
  • A global overview showing market data for North America, Europe, Asia-Pacific and Latin America, Africa and the Middle East (LAAM).
  • Emerging opportunities and potential investment opportunity areas for IVD.
  • Technology patent trends relating to IVD.
  • Profiles for more than 20 companies in the industry with significant contributions and market shares.

Report Includes:

  • 47 data tables and 21 additional tables
  • An overview of the global market for in vitro diagnostics (IVD) within the industry
  • Analyses of global market trends, with data from 2019-2020, and projections of compound annual growth rates (CAGRs) through 2025
  • Assessment of market dynamics such as drivers, restraints, opportunities, and identification of growth inhibiting areas that affect the global market
  • Evaluation of market size and forecast, and technological advancements within the industry; and market share analysis of the global IVD market by application, segment and region
  • A look at how the rise in the number of diseases like respiratory infections, hospital acquired infections (HAI), and sexually transmitted diseases are creating a constant need for IVD testing in hospitals and laboratories
  • Coverage of technologies such as IVD for neglected infectious diseases, chemistry-based portable analysis and discussion on advantages of microfluidic platform based POC tests
  • Detailed description on COVID-9 pandemic, including symptoms, and progression; information on coronavirus disease 2019 testing basics and impact analysis of COVID-19 on the IVD market
  • Comprehensive company profiles of major market players, including Abbott Diagnostics Inc., Beckman Coulter, Becton, Dickinson and Co., Bio-Rad Laboratories, Roche Diagnostics, Siemens Healthcare and Thermo Fisher Scientific Inc.

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Intended Readership
  • Scope of Report
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

  • Global Market Trends

Chapter 3 Market Landscape

  • COVID-19 Global Pandemic
  • Coronavirus Disease 2019 Testing Basics
  • Diagnostic Tests with Alternative Options
  • Molecular Diagnostic Tests
  • Increasing Access to Testing
  • Antigen Tests
  • Antibody (Serology) Tests
  • In Vitro Diagnostic Testing EUAs
  • Diagnostic Tests
  • Serology/Antibody Tests
  • Tests for the Management of COVID-19 Patients
  • Market Overview and Segmentation
  • Key Findings
  • Factors Influencing the Global IVD Market
  • Drivers
  • Challenges
  • Regulatory Landscape
  • IVD Regulations in North America
  • IVD Regulations in Europe
  • IVD Regulations in Asia-Pacific
  • IVD Regulations in LAAM (Latin America, Africa and Middle East)

Chapter 4 Global Market for IVD by Product Segment

  • Immunochemistry
  • POC IVD
  • Molecular Diagnostic Testing
  • Hematology
  • Clinical Microbiology
  • Tissue Diagnostic Testing
  • Trends in IVD Segments
  • Competitive Structure
  • Market Share Analysis

Chapter 5 Global Market for Immunochemistry Testing

  • Blood Gas, Electrolytes and Metabolites (BGEM)
  • Endocrine
  • Infectious Diseases
  • Cancer
  • Urinalysis
  • Diabetes
  • Cardiology
  • Blood Screening
  • Others
  • FDA Product Approvals in 2020

Chapter 6 Global Market for POC Testing

  • Glucose Testing
  • BGEM
  • Cardiac Marker Testing
  • Infectious Disease Testing
  • Pregnancy and Fertility Testing
  • Drug and Alcohol Abuse Testing
  • Hematology and Hemostasis Testing
  • Cholesterol Testing
  • Urine Chemistry Testing
  • Tumor Marker Testing
  • Other Types of POC Testing
  • FDA Product Approvals in 2020

Chapter 7 Global Market for Hematology Testing

  • Routine Hematology Tests
  • Hemostasis
  • FDA Product Approvals in 2020

Chapter 8 Global Market for Molecular Diagnostic Testing

  • Infectious Diseases
  • Blood Screening
  • Oncology
  • Genetic Testing
  • Others (Companion Diagnostics, Prenatal Genetic Tests and Rare Diseases)
  • FDA Product Approvals in 2020

Chapter 9 Global Market for Clinical Microbiology Testing

  • Blood Culture
  • General Culture (Urine/Saliva/Stool/Sputum/CSF and Other Body Fluids)
  • Identification and Antibiotic Susceptibility Testing
  • FDA Product Approvals in 2020

Chapter 10 Global Market for Tissue Diagnostic Testing

  • Cancer Diagnosis
  • Tissue Typing
  • Pathogen Detection

Chapter 11 Regional Analysis

  • Introduction
  • North America
  • Europe
  • Asia-Pacific
  • LAAM
  • International Health Expenditure and Trends
  • North America
  • Europe
  • Western Europe
  • Central and Eastern Europe
  • Asia-Pacific
  • Latin America, Africa and Middle East (LAAM)

Chapter 12 Market Trends

  • End Users
  • Trends
  • Product Categories
  • Trends
  • Technology Trends
  • Industry Developments
  • Opportunities
  • IVD for Neglected Infectious Diseases
  • Portable Devices Compatible with Simple Detection Platforms
  • Chemistry-Based Portable Analyzers
  • Improved Sample Preservation Technologies
  • New Detection Technologies
  • Alternative Technologies to PCR
  • Key Biomarkers for Diseases of the Developing World
  • Microfluidic Platform-based POC Tests for Remote Settings
  • Combining Multiple Detection Technologies into a Single Instrument

Chapter 13 Mergers and Acquisitions

Chapter 14 Patent Review

  • Coronavirus COVID-19 Diagnostics

Chapter 15 Company Profiles

  • ABBOTT DIAGNOSTICS INC.
  • ALERE SAN DIEGO INC.
  • ASCENSIA DIABETES CARE
  • BECKMAN COULTER (PART OF DANAHER)
  • BECTON DICKINSON AND CO.
  • BIOMERIEUX
  • BIO-RAD
  • DANAHER CORP.
  • ELITECH GROUP
  • HOLOGIC INC.
  • INSTRUMENTATION LABORATORY
  • KEMENTEC A/S
  • ORTHO CLINICAL DIAGNOSTICS
  • ROCHE DIAGNOSTICS CORP.
  • QUIDEL CORP.
  • SIEMENS HEALTHCARE DIAGNOSTICS INC.
  • SYSMEX
  • THERMO FISHER SCIENTIFIC INC.
  • TRANSASIA BIO-MEDICALS
  • WERFEN GROUP

Chapter 16 Appendix

  • List of IVD Market Participants
  • List of Acronyms
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.